Giorgio Sesti

Pubblicazioni

Titolo Pubblicato in Anno
Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile ATHEROSCLEROSIS 2017
Insulin-like growth factor-1 is a negative modulator of glucagon secretion ONCOTARGET 2017
Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals PLOS ONE 2017
Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity ACTA DIABETOLOGICA 2017
Cardiovascular effects of glucagon-like peptide-1 receptor agonist therapies in patients with type 1 diabetes DIABETES, OBESITY AND METABOLISM 2017
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects BEHAVIOURAL BRAIN RESEARCH 2017
Liraglutide improves cardiac function in patients with type 2 diabetes and chronic heart failure ENDOCRINE 2017
Uric acid is associated with inflammatory biomarkers and induces inflammation via activating the NF-κB signaling pathway in HepG2 cells ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY 2017
Plasma kisspeptin levels are associated with insulin secretion in nondiabetic individuals PLOS ONE 2017
Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis). data from randomized controlled trials DIABETES, OBESITY AND METABOLISM 2017
Duodenal sodium/glucose co-transporter 1 expression under fasting conditions is associated with postload hyperglycemia THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2017
Association between hemoglobin glycation index and hepatic steatosis in non-diabetic individuals DIABETES RESEARCH AND CLINICAL PRACTICE 2017
Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events. A comprehensive meta-analysis of randomized controlled trials INTERNATIONAL JOURNAL OF CARDIOLOGY 2017
Risk reclassification ability of uric acid for cardiovascular outcomes in essential hypertension INTERNATIONAL JOURNAL OF CARDIOLOGY 2017
Glucagon-like peptide-1 receptor agonists and atrial fibrillation. a systematic review and meta-analysis of randomised controlled trials JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2017
Predictors of response to glucagon-like peptide-1 receptor agonists. a meta-analysis and systematic review of randomized controlled trials ACTA DIABETOLOGICA 2017
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients ARCHIVES OF GERONTOLOGY AND GERIATRICS 2017
Defining aging phenotypes and related outcomes. clues to recognize frailty in hospitalized older patients THE JOURNALS OF GERONTOLOGY. SERIES A, BIOLOGICAL SCIENCES AND MEDICAL SCIENCES 2017
Comparative Impact of hypoglycemic agents on severity and extent of myocardial ischemia in patients with type 2 Diabetes mellitus undergoing myocardial perfusion scintigraphy JOURNAL OF CARDIOVASCULAR PHARMACOLOGY 2016
Frequency of 1-h post-load glucose ≥155 mg/dl among individuals with different glucose tolerance conditions NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2016

ERC

  • LS4_9
  • LS4_10

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

- Meccanismi molecolari dell’azione insulinica e della funzione pancreatica;

- Fisiopatologia del diabete tipo 2 e dell’obesità;

- Genetica dell’insulino-resistenza, del diabete tipo 2 e dell’obesità;

- Sindrome metabolica e prediabete;

- Obesità metabolicamente sana;

- Trattamento del diabete tipo 2;

- Ruolo dell’IGF-1 nella patologia cardiovascolare e metabolica;

- Infiammazione, disfunzione endoteliale e patologia cardiovascolare;

- Epatopatie croniche e danno cardio-metabolico

Keywords

Diabetes Mellitus
obesity
cardiovascular disease

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma